{"id":"W4410031891","doi":"10.1080/13696998.2025.2498853","title":"Axicabtagene ciloleucel compared to standard of care in Canadian patients with relapsed or refractory large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada); Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"Gilead Sciences","keywords":"Medicine; Refractory (planetary science); Standard of care; Lymphoma; Oncology; Internal medicine; Pediatrics; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002058971,0.0001357072,0.00119056,0.0009523096,0.00003981862,0.00001083324,0.000400472,0.0001825152,0.0005868387],"category_scores_gemma":[0.0007946139,0.00008540181,0.0002949139,0.0009020664,0.0001129161,0.00004348809,0.00007086544,0.000380615,5.555898e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002151214,"about_ca_system_score_gemma":0.007633735,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.006844186,"about_ca_topic_score_gemma":0.1605103,"domain_scores_codex":[0.9976683,0.0002776074,0.0009105668,0.0001733806,0.0006592125,0.0003109563],"domain_scores_gemma":[0.9977395,0.0004836457,0.0003994417,0.0003556725,0.0004869893,0.0005347382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5966085,0.003755914,0.342668,0.0006361875,0.004465738,0.0001559396,0.002472573,0.001430307,0.0002597578,0.0001122922,0.0008172485,0.04661759],"study_design_scores_gemma":[0.477024,0.01045492,0.4383324,0.001748271,0.002115805,0.000009437954,0.002345091,0.001813603,0.003473247,0.0000197735,0.06235499,0.000308435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970963,0.0001582199,0.00004299205,0.0006934057,0.0002963599,0.0009287861,0.0001672659,0.000001615632,0.0006150792],"genre_scores_gemma":[0.9993294,0.0001225979,0.00004955372,0.0002938026,0.00005039934,0.00001155768,0.00001518135,0.00001435862,0.0001131052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1536662,"threshold_uncertainty_score":0.9997693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01783357241865267,"score_gpt":0.319916550429289,"score_spread":0.3020829780106363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}